secwatch / observer
8-K filed April 28, 2026, 7:59 PM ET ticker ZBH CIK 0001136869
earnings confidence high sentiment positive materiality 0.75

ZBH Q1 net sales $2.09B (+9.3% reported); adj EPS $2.09 (+15.5%); raises FY adj EPS guidance to $8.40-$8.55

ZIMMER BIOMET HOLDINGS, INC.

2026-Q1 EPS reported $1.22 vs consensus $1.88 ▼ miss (-35.2%)

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ZIMMER BIOMET HOLDINGS, INC. reported the fiscal year ending December 31, 2026 results: EPS $8.40 - $8.55. Guidance raised.

Period
the fiscal year ending December 31, 2026
EPS
$8.40 - $8.55
Guidance
raised
Result
guidance update
Exact text from the filing
The Company is updating its full-year 2026 financial guidance as follows:
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ZIMMER BIOMET HOLDINGS, INC. reported the quarter ended March 31, 2026 results: revenue $2.087 billion, net income $238.1 million, EPS $1.22.

Period
the quarter ended March 31, 2026
Revenue
$2.087 billion
Net income
$238.1 million
EPS
$1.22
Result
reported results
Exact text from the filing
The Company reported first quarter net sales of $2.087 billion, an increase of 9.3% over the prior year period, an increase of 6.8% on a constant currency 1 basis and an increase of 2.9% on an organic constant currency 1 basis.
View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

ZIMMER BIOMET HOLDINGS, INC. filing history →

Source: SEC EDGAR
accession 0001193125-26-183411
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.